Impact of somatic mutations on recurrence free survival (RFS) and overall survival (OS) for resected nonsmall cell lung cancer (NSCLC): results from the Japan Molecular Epidemiology for lung cancer study (JME).

被引：0
|
作者：
Tamiya, Akihiro
Koh, Yasuhiro
Kubo, Akihito
Ando, Masahiko
Isa, Shun-ichi
Saka, Hideo
Yoshimoto, Naoki
Serizawa, Masakuni
Takeo, Sadanori
Adachi, Hirofumi
Tagawa, Tsutomu
Kawashima, Osamu
Yamashita, Motohiro
Kataoka, Kazuhiko
Ichinose, Yukito
Takeuchi, Yukiyasu
Watanabe, Katsuya
Matsumura, Akihide
Kawaguchi, Tomoya
机构：
[1] Natl Hosp Org Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[2] Wakayama Med Univ, Wakayama, Japan
[3] Aichi Med Univ, Sch Med, Div Resp Med & Allergol, Nagakute, Aichi, Japan
[4] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan
[5] Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan
[6] Osaka City Univ, Grad Sch Med, Dept Clin Oncol, Osaka, Japan
[7] Shizuoka Canc Ctr Res Inst, Div Drug Discovery & Dev, Nagaizumi, Shizuoka, Japan
[8] Natl Hosp Org Kyushu Med Ctr, Fukuoka, Fukuoka, Japan
[9] Hokkaido Canc Ctr, Natl Hosp Org, Dept Thorac Surg, Sapporo, Hokkaido, Japan
[10] Natl Hosp Org Nagasaki Med Ctr, Omura, Japan
[11] Natl Hosp Org Shibukawa Med Ctr, Shibukawa, Japan
[12] Natl Hosp Org Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[13] Natl Hosp Org Iwakuni Clin Ctr, Iwakuni, Japan
[14] Natl Hosp Org Kyushu Canc Ctr, Fukuoka, Fukuoka, Japan
[15] Natl Hosp Org Toneyama Natl Hosp, Toyonaka, Osaka, Japan
[16] Natl Hosp Org Yokohama Med Ctr, Yokohama, Kanagawa, Japan
[17] Natl Hosp Org Kinki Chuo Chest Med Ctr, Osaka, Japan
[18] Osaka City Univ, Grad Sch Med, Dept Resp Med, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.8549
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8549
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer study
    Tamiya, Akihiro
    Koh, Yasuhiro
    Isa, Shun-ichi
    Kubo, Akihito
    Ando, Masahiko
    Saka, Hideo
    Yoshimoto, Naoki
    Takeo, Sadanori
    Adachi, Hirofumi
    Tagawa, Tsutomu
    Kawashima, Osamu
    Yamashita, Motohiro
    Kataoka, Kazuhiko
    Takenoyama, Mitsuhiro
    Takeuchi, Yukiyasu
    Watanabe, Katsuya
    Matsumura, Akihide
    Kawaguchi, Tomoya
    CANCER MEDICINE, 2020, 9 (07): : 2343 - 2351
  • [2] Factors Associated With Local and Distant Recurrence and Survival in Patients With Resected Nonsmall Cell Lung Cancer
    Varlotto, John M.
    Recht, Abram
    Flickinger, John C.
    Medford-Davis, Laura N.
    Dyer, Ann M.
    DeCamp, Malcolm M.
    CANCER, 2009, 115 (05) : 1059 - 1069
  • [3] Disease-free survival (DFS) as a predictor of overall survival (OS) in completely resected early stage non-small cell lung cancer (NSCLC)
    West, H.
    Hu, X.
    Burke, T.
    Walker, M. S.
    Wang, Y.
    Samkari, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S74 - S75
  • [4] Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancer
    Cata, Juan P.
    Gottumukkala, Vijaya
    Thakar, Dilip
    Keerty, Dinesh
    Gebhardt, Rodolfo
    Liu, Diane D.
    JOURNAL OF CLINICAL ANESTHESIA, 2014, 26 (01) : 3 - 17
  • [5] Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Nonsmall Cell Lung Cancer
    Libby, Daniel M.
    Libby, Laura J.
    Ma, Xiaoyue
    Chua, Jason
    Blow, Tahj
    Razavi, Peyman
    Saxena, Ashish
    CLINICAL LUNG CANCER, 2025, 26 (02) : 116 - 123
  • [6] Prolonged overall survival of patients with leptomeningeal carcinomatosis from nonsmall cell lung cancer
    Ju, Yanfang
    Sun, Shengjie
    Wang, Jinliang
    Jiao, Shunchang
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (05) : 126 - 129
  • [7] The impact of alternative dosing regimens on overall survival (OS) in the treatment of non small cell lung cancer (NSCLC) with Erlotinib
    Pembroke, C.
    Pembroke, T.
    Vigneswaran, V.
    Rowley, K.
    LUNG CANCER, 2012, 75 : S10 - S10
  • [8] Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study
    Lin, Xiaoping
    Yao, Jianfeng
    Huang, Baoshan
    Chen, Tebin
    Xie, Liutian
    Huang, Rongfu
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2024, 33 (04) : 376 - 385
  • [9] Overall survival (OS) of EGFR mutation-positive nonsmall cell lung cancer (NSCLC): 1,660 Japanese patients (pts)
    Yoshioka, Hiroshige
    Sugawara, Shunichi
    Yoshida, Kazushi
    Murakami, Shuji
    Kim, Young Hak
    Atagi, Shinji
    Imamura, Fumio
    Takeda, Koji
    Seto, Takashi
    Morita, Satoshi
    Ohe, Yuichiro
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] RISK OF RECURRENCE AND OVERALL SURVIVAL OF SURGICALLY RESECTED NON SMALL CELL LUNG CANCER IN ELDERLY PATIENTS
    Al-Alao, B.
    Mc Govern, E. N.
    Young, V. N.
    O'Byrne, K.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S54 - S54
12345